# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-22-000096
Filing Date
2022-11-09
Accepted
2022-11-09 16:06:52
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cntx-20220930.htm iXBRL | 10-Q | 1028733
2 | EX-10.2 | tyligand-cntxamendno3proce.htm | EX-10.2 | 29882
3 | EX-10.3 | lonzacontextdmsa.htm | EX-10.3 | 225900
4 | EX-10.4 | context-lonzalicenseagreem.htm | EX-10.4 | 213219
5 | EX-31.1 | cntx-20220930x10qexhibit311.htm | EX-31.1 | 9118
6 | EX-31.2 | cntx-20220930x10qexhibit312.htm | EX-31.2 | 9165
7 | EX-32.1 | cntx-20220930x10qexhibit321.htm | EX-32.1 | 6312
13 |  | image_0.jpg | GRAPHIC | 19466
| Complete submission text file | 0001842952-22-000096.txt |  | 5304660

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cntx-20220930.xsd | EX-101.SCH | 34876
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cntx-20220930_cal.xml | EX-101.CAL | 33042
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cntx-20220930_def.xml | EX-101.DEF | 195783
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cntx-20220930_lab.xml | EX-101.LAB | 444739
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cntx-20220930_pre.xml | EX-101.PRE | 306927
53 | EXTRACTED XBRL INSTANCE DOCUMENT | cntx-20220930_htm.xml | XML | 608939

Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 221372558
SIC: 2834 Pharmaceutical Preparations